McGill Alert / Alerte de McGill

Updated: Mon, 07/15/2024 - 16:07

Gradual reopening continues on downtown campus. See Campus Public Safety website for details.

La réouverture graduelle du campus du centre-ville se poursuit. Complément d'information : Direction de la protection et de la prévention.

Home

Amine Kamen

Academic title(s): 

Professor, Canada Research Chair in Bioprocessing of Viral Vaccines

National Research Council of Canada Research Emeritus

Amine Kamen
Contact Information
Email address: 
amine.kamen [at] mcgill.ca
Phone: 
514.398.5775
Office: 
McConnell Engineering Building, Room 363
Degree(s): 

Ph.D. Ecole Polytechnique de Montreal;
Doct.-Ing. Ecole des Mines de Paris

Areas of interest: 
  • Cell Culture Engineering
  • Bioprocess Optimization and Scale-up
  • Process Analytical Technologies and Process Control
  • Viral Vaccines Manufacturing
  • Viral Vectors and Nanoparticules for Gene Delivery and Vaccination
Courses: 
  • BIEN 500: Special Topics in Bioengineering 1
  • BIEN 590: Cell Culture Engineering
  • BIEN 675: Process Analytical Technologies and Data Sciences
  • BIEN 680: Bioprocessing of Vaccines
  • BIEN 685: Gene and Cell Therapy Viral Vectors Biomanufacturing
Selected publications: 

Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed.
Kiesslich S, Vila-Chã Losa JP, Gélinas JF, Kamen AA. J Biotechnol. 2020 Feb 20;310:32-39. doi: 10.1016/j.jbiotec.2020.01.015. Epub 2020 Jan 30.
PubMed PMID: 32006630.

Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells.
Do Minh A, Tran MY, Kamen AA. Methods Mol Biol. 2020;2086:77-83. doi: 10.1007/978-1-0716-0146-4_6.
PubMed PMID: 31707669.

Adeno-Associated Viral Vectors for Homology-Directed Generation of CAR-T Cells.
Moço PD, Aharony N, Kamen A. Biotechnol J. 2020 Jan;15(1):e1900286. doi: 10.1002/biot.201900286. Epub 2019 Nov 19. Review.
PubMed PMID: 31642193.

Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.
Vaccine.Venereo-Sánchez A, Fulton K, Koczka K, Twine S, Chahal P, Ansorge S, Gilbert R, Henry O, Kamen A. 2019 Nov 8;37(47):7100-7107. doi: 10.1016/j.vaccine.2019.07.057.
Epub 2019 Jul 26. PubMed PMID: 31358407.

Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
Shen CF, Guilbault C, Li X, Elahi SM, Ansorge S, Kamen A, Gilbert R. Vaccine. 2019 Nov 8;37(47):6996-7002. doi: 10.1016/j.vaccine.2019.07.003.
Epub 2019 Jul 6. PubMed PMID: 31288997.

Please see NCBI for a more comprehensive listing.

Link(s): 
Website
Back to top